Joji Ishida
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
-
- Neuroblastoma Research and Treatments
Papers in
- Genetics 26
- Glioma Diagnosis and Treatment 25
- Virus-based gene therapy research 3
-
- Cell Adhesion Molecules Research 6
- Co-authors
- Kazuhiko KurozumiIsao DateTomotsugu IchikawaKentaro FujiiYosuke ShimazuYoshihiro OtaniToshihiko ShimizuYusuke Tomita
- Journals
- Brain Tumor Pathology (8 papers)Scientific Reports (3 papers)Journal of Neuro-Oncology (3 papers)World Neurosurgery (2 papers)Neuro-Oncology (2 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Joji Ishida
45 papers receiving 548 citations
Peers
Comparison fields: 5 of 72
- Genetics 196
- Neurology 83
- Immunology and Allergy 32
- Cancer Research 76
- Molecular Biology 229
Countries citing papers authored by Joji Ishida
This map shows the geographic impact of Joji Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joji Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joji Ishida more than expected).
Fields of papers citing papers by Joji Ishida
This network shows the impact of papers produced by Joji Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joji Ishida. The network helps show where Joji Ishida may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joji Ishida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 3 | |
| 10 | 2021 | 3 | |
| 11 | 2020 | 7 | |
| 12 | 2019 | 15 | |
| 13 | 2019 | 18 | |
| 14 | 2019 | 34 | |
| 15 | 2019 | 6 | |
| 16 | 2017 | 11 | |
| 17 | 2016 | 14 | |
| 18 | 2015 | 11 | |
| 19 | 2014 | 23 | |
| 20 | 2013 | 23 |
About Joji Ishida
Joji Ishida is a scholar working on Genetics, Immunology and Allergy, Neurology, Cancer Research and Otorhinolaryngology, having authored 49 papers that have together received 551 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (25 papers), Meningioma and schwannoma management (7 papers), Neuroblastoma Research and Treatments (6 papers), Cell Adhesion Molecules Research (6 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Pituitary Gland Disorders and Treatments (4 papers), interferon and immune responses (3 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Genetics (196 citations), Neurology (83 citations), Immunology and Allergy (32 citations), Cancer Research (76 citations) and Molecular Biology (229 citations). Joji Ishida has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kazuhiko Kurozumi, Isao Date, Tomotsugu Ichikawa, Kentaro Fujii, Yosuke Shimazu, Yoshihiro Otani, Toshihiko Shimizu, Yusuke Tomita, James T. Rutka and Dilakshan Srikanthan. Their work appears in journals such as Brain Tumor Pathology, Scientific Reports, Journal of Neuro-Oncology, World Neurosurgery and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.